Prostate Cancer - Results from #2080

T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. September 29, 2023

Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study. September 29, 2023

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer. September 29, 2023

MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation. September 29, 2023

Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer. September 29, 2023

The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer. September 28, 2023

The utility of [18F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate Resistant Prostate Cancer Patients (nmCRPCp): Diagnostic performance and Impact on Management. September 28, 2023

Association Between Urologist Merit-based Incentive Payment System Performance and Quality of Prostate Cancer Care. September 28, 2023

Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis. September 28, 2023

Conditional Risks of Biochemical Failure and Prostate Cancer-Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials. September 28, 2023

Precision intervention for prostate cancer: Re-evaluating who is at risk. September 28, 2023

A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance. September 28, 2023

Docetaxel radiosensitizes castration resistant prostate cancer by downregulating CAV-1. September 27, 2023

Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis. September 27, 2023

Low-Value Prostate Cancer Screening Among Young Men With Private Insurance. September 27, 2023

Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy. September 27, 2023

The diagnostic accuracy of 68 Ga-PSMA-PET/CT in primary staging of patients with high-risk nonmetastatic prostate cancer treated with radical prostatectomy: A single-center cohort analysis. September 27, 2023

Geriatric assessment - What should be done and considered before starting therapy of mHSPC and mCRPC? September 27, 2023

Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia. September 26, 2023

Rare Genetic Drivers of Lethal Prostate Cancer. September 26, 2023

Page 105 of 1439